Norway’s Algeta to develop cancer therapies Oslo-based anticancer company Algeta has closed a series A financing round totaling €23 million. 12 Oct 2005 News
New bio fund launched – and investment begins A new life-science fund said it raised €240.3 million – and promptly announced its first two investments. 12 Oct 2005 News